Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment
In the last few years, nonsteroidal aromatase inhibitors (AIs) have been emerged as promising agents for treating hormone-dependent breast cancer in postmenopausal women because of their inhibitory effect on estrogen synthesis. Indeed, these compounds can block the activity of aromatase, the enzyme...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Heteroatom Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2022/5349279 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849692607043600384 |
|---|---|
| author | Huda R. M. Rashdan Ihsan A. Shehadi |
| author_facet | Huda R. M. Rashdan Ihsan A. Shehadi |
| author_sort | Huda R. M. Rashdan |
| collection | DOAJ |
| description | In the last few years, nonsteroidal aromatase inhibitors (AIs) have been emerged as promising agents for treating hormone-dependent breast cancer in postmenopausal women because of their inhibitory effect on estrogen synthesis. Indeed, these compounds can block the activity of aromatase, the enzyme that intervenes in the last steps of estrogen production pathway. Triazoles are the core structures of nonsteroidal AIs. The nitrogen atom of the triazole moiety plays a fundamental role in the aromatase functionality by interacting with the iron ions of the heme group. In general, AIs possess numerous advantages as they quench the last step of estrogen synthesis without any inhibitory effects on the production of other steroids produced via the same pathway. Some AIs as anastrozole, letrozole, and vorozole have already been approved by the Food and Drug Administration in the treatment of breast cancer. The previously mentioned compounds present severe and adverse effects as polycystic ovary syndrome (PCOS), resistance onset on long-term treatments, and a higher risk of bone fractures. This review focuses intensively on the role of AIs in the treatment of hormone-sensitive types of cancers, especially the role of triazoles as nonsteroidal AIs. Also, the review provides an overview about the chemistry of triazoles along with the different methods by which the v-triazoles and s-triazoles are synthesized. |
| format | Article |
| id | doaj-art-97e982112faa48fd8efbfda4f98714f6 |
| institution | DOAJ |
| issn | 1098-1071 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Heteroatom Chemistry |
| spelling | doaj-art-97e982112faa48fd8efbfda4f98714f62025-08-20T03:20:39ZengWileyHeteroatom Chemistry1098-10712022-01-01202210.1155/2022/5349279Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer TreatmentHuda R. M. Rashdan0Ihsan A. Shehadi1Chemistry of Natural and Microbial Products DepartmentChemistry DepartmentIn the last few years, nonsteroidal aromatase inhibitors (AIs) have been emerged as promising agents for treating hormone-dependent breast cancer in postmenopausal women because of their inhibitory effect on estrogen synthesis. Indeed, these compounds can block the activity of aromatase, the enzyme that intervenes in the last steps of estrogen production pathway. Triazoles are the core structures of nonsteroidal AIs. The nitrogen atom of the triazole moiety plays a fundamental role in the aromatase functionality by interacting with the iron ions of the heme group. In general, AIs possess numerous advantages as they quench the last step of estrogen synthesis without any inhibitory effects on the production of other steroids produced via the same pathway. Some AIs as anastrozole, letrozole, and vorozole have already been approved by the Food and Drug Administration in the treatment of breast cancer. The previously mentioned compounds present severe and adverse effects as polycystic ovary syndrome (PCOS), resistance onset on long-term treatments, and a higher risk of bone fractures. This review focuses intensively on the role of AIs in the treatment of hormone-sensitive types of cancers, especially the role of triazoles as nonsteroidal AIs. Also, the review provides an overview about the chemistry of triazoles along with the different methods by which the v-triazoles and s-triazoles are synthesized.http://dx.doi.org/10.1155/2022/5349279 |
| spellingShingle | Huda R. M. Rashdan Ihsan A. Shehadi Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment Heteroatom Chemistry |
| title | Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment |
| title_full | Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment |
| title_fullStr | Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment |
| title_full_unstemmed | Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment |
| title_short | Triazoles Synthesis & Applications as Nonsteroidal Aromatase Inhibitors for Hormone-Dependent Breast Cancer Treatment |
| title_sort | triazoles synthesis applications as nonsteroidal aromatase inhibitors for hormone dependent breast cancer treatment |
| url | http://dx.doi.org/10.1155/2022/5349279 |
| work_keys_str_mv | AT hudarmrashdan triazolessynthesisapplicationsasnonsteroidalaromataseinhibitorsforhormonedependentbreastcancertreatment AT ihsanashehadi triazolessynthesisapplicationsasnonsteroidalaromataseinhibitorsforhormonedependentbreastcancertreatment |